A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
The purpose of this study is to investigate the safety and efficacy of MK0991 in patients
 with deep-seated mycoses.
Inclusion Criteria:

 -  Japanese Patients In Whom A Causative Fungus Is Detected Before Treatment With The
 Study Drug Or Patients With Strongly Suspected Deep-Seated Fungal Infection Due To
 Candida species (Spp.) Or Aspergillus Spp.

 Exclusion Criteria:

 -  Patients With Mycoses Other Than Ones Due To Candida Spp. Or Aspergillus Spp.

 -  Patients Who Will Receive Other Systemic Antifungal Agents For The First Time In
 Screening Period.